that the Pharmaq Chile Group will not own or hold cash or cash equivalents in excess of the
provided that nothing in this Clause 13.20 (d) shall require the Pharmaq Chile Group to do
so where such cash/cash equivalent transfer would cause the Pharmaq Chile Group to incur
material costs or expenses (including any material tax liability).
14.
INCURRENCE TEST
(a)
For the purpose of this Agreement, the "Incurrence Test" will be met if:
(i)
